Evidence map›Paper›PMID 34286877›Full record

ArticleInternational journal of geriatric psychiatry2021

Impact of agitation in long-term care residents with dementia in the United States.

Howard Fillit, Myrlene S Aigbogun, Patrick Gagnon-Sanschagrin, Martin Cloutier, Mikhaïl Davidson, Elizabeth Serra, Annie Guérin, Ross A Baker, Christy R Houle, George Grossberg

Open access · hybridAbstract read
In one paragraph

Article in International journal of geriatric psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  6. Article
  7. Agitation in dementia: Evidence-based consensus recommendations.Journal of the Chinese Medical Association : JCMA · 2026
    Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Howard FillitGeriatric Medicine, Palliative Care and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Myrlene S AigbogunHealth Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ, USA.
Patrick Gagnon-SanschagrinAnalysis Group, Inc., Montreal, QC, Canada.
Martin CloutierAnalysis Group, Inc., Montreal, QC, Canada.
Mikhaïl DavidsonAnalysis Group, Inc., Montreal, QC, Canada.
Elizabeth SerraAnalysis Group, Inc., Montreal, QC, Canada.
Annie GuérinAnalysis Group, Inc., Montreal, QC, Canada.
Ross A BakerHealth Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ, USA.
Christy R HouleHealth Economics and Outcomes Research, Lundbeck Pharmaceuticals, Deerfield, IL, USA.
George GrossbergGeriatric Psychiatry, Saint Louis University School of Medicine, Saint Louis, MO, USA.
Group for Research in Decision Analysis · CAIcahn School of Medicine at Mount Sinai · USLundbeck (United States) · USOtsuka Pharmaceutical (Spain) · ESOtsuka (United States) · USSaint Louis University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo describe characteristics and compare clinical outcomes including falls, fractures, infections, and neuropsychiatric symptoms (NPS) among long-term care residents with dementia with and without agitation.

methodsA cross-sectional secondary analysis of administrative healthcare data was conducted whereby residents with dementia residing in a long-term care facility for ≥12 months were identified from the AnalytiCare LLC database (10/2010-06/2014) and were classified into mutually exclusive cohorts (Agitation Cohort or No-Agitation Cohort) based on available agitation-related symptoms. Entropy balancing was used to balance demographic and clinical characteristics between the two cohorts. The impact of agitation on clinical outcomes was compared between balanced cohorts using weighted logistic regression models.

resultsThe study included 6,265 long-term care residents with dementia among whom, 3,313 were included in the Agitation Cohort and 2,952 in the No-Agitation Cohort. Prior to balancing, residents in the Agitation Cohort had greater dementia-related cognitive impairment and clinical manifestations compared to the No-Agitation Cohort. After balancing, residents with and without agitation, respectively, received a median of five and four distinct types of medications (including antipsychotics). Further, compared to residents without agitation, those with agitation were significantly more likely to have a recorded fall (OR = 1.58), fracture (OR = 1.29), infection (OR = 1.18), and other NPS (OR = 2.11).

conclusionsAgitation in long-term care residents with dementia was associated with numerically higher medication use and an increased likelihood of experiencing falls, fractures, infections, and additional NPS compared to residents without agitation, highlighting the unmet need for effective management of agitation symptoms in this population.

Indexed as

DementiaLong-Term CareAnxietyCross-Sectional StudiesHumansNursing HomesPsychomotor AgitationUnited Statesagitationdementiafallsfracturesinfectionslong-term caremedication useneuropsychiatric symptoms

Identifiers

PMID34286877
PMCPMC9291552
OpenAlexW3186432706

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.